These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38852261)

  • 1. Evaluation of the T25FW in minimally disabled people with multiple sclerosis.
    Helmlinger B; Pinter D; Hechenberger S; Bachmaier G; Khalil M; Heschl B; Damulina A; Pichler A; Enzinger C
    J Neurol Sci; 2024 Jul; 462():123073. PubMed ID: 38852261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.
    Wanitschek A; Seebacher B; Muehlbacher A; Brenneis C; Ehling R
    Mult Scler Relat Disord; 2024 May; 85():105532. PubMed ID: 38452648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.
    Jakimovski D; Kavak KS; Zakalik K; Bromley L; Ozel O; Qutab N; Eckert SP; Kolb C; Weinstock-Guttman B
    Mult Scler J Exp Transl Clin; 2022; 8(2):20552173221099186. PubMed ID: 35571975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
    Stellmann JP; Vettorazzi E; Poettgen J; Heesen C
    J Neurol Sci; 2014 Nov; 346(1-2):99-106. PubMed ID: 25156343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
    Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enrichment strategy for clinical trials in SPMS.
    Koch MW; Metz L; Cutter G
    Mult Scler; 2021 Oct; 27(12):1884-1893. PubMed ID: 33404355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of Timed 25-Foot Walk Values in Predicting Maximum Walking Distance in Persons with Multiple Sclerosis.
    Alshamrani F; Berger W; Alnajashi H; Payne MWC; Morrow SA
    Int J MS Care; 2020; 22(5):215-218. PubMed ID: 33177957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective sensor-based gait measures reflect motor impairment in multiple sclerosis patients: Reliability and clinical validation of a wearable sensor device.
    Flachenecker F; Gaßner H; Hannik J; Lee DH; Flachenecker P; Winkler J; Eskofier B; Linker RA; Klucken J
    Mult Scler Relat Disord; 2020 Apr; 39():101903. PubMed ID: 31927199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The timed 25-foot walk in a large cohort of multiple sclerosis patients.
    Kalinowski A; Cutter G; Bozinov N; Hinman JA; Hittle M; Motl R; Odden M; Nelson LM
    Mult Scler; 2022 Feb; 28(2):289-299. PubMed ID: 34100297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
    Bethoux FA; Palfy DM; Plow MA
    Int J Rehabil Res; 2016 Jun; 39(2):134-9. PubMed ID: 26926380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Koch MW; Mostert JP; Wolinsky JS; Lublin FD; Uitdehaag B; Cutter GR
    Neurology; 2021 Oct; 97(16):e1560-e1570. PubMed ID: 34433679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
    Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
    Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets.
    Koch MW; Mostert J; Uitdehaag B; Cutter G
    Mult Scler; 2020 Oct; 26(12):1540-1549. PubMed ID: 31517591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
    Behrens J; Pfüller C; Mansow-Model S; Otte K; Paul F; Brandt AU
    J Neuroeng Rehabil; 2014 May; 11():89. PubMed ID: 24886525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.